Silexion Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLXN and other ETFs, options, and stocks.

About SLXN

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel. 

CEO
Ilan Hadar
CEOIlan Hadar
Employees
14
Employees14
Headquarters
Ramat-Gan, Tel Aviv
HeadquartersRamat-Gan, Tel Aviv
Founded
2008
Founded2008
Employees
14
Employees14

SLXN Key Statistics

Market cap
2.02M
Market cap2.02M
Price-Earnings ratio
-0.01
Price-Earnings ratio-0.01
Dividend yield
Dividend yield
Average volume
268.04K
Average volume268.04K
High today
$0.3759
High today$0.3759
Low today
$0.353
Low today$0.353
Open price
$0.37
Open price$0.37
Volume
77.09K
Volume77.09K
52 Week high
$80.00
52 Week high$80.00
52 Week low
$0.3501
52 Week low$0.3501

Stock Snapshot

Silexion Therapeutics(SLXN) stock is priced at $0.36, giving the company a market capitalization of 2.02M. It carries a P/E multiple of -0.01.

As of 2026-08-29, Silexion Therapeutics(SLXN) stock has fluctuated between $0.35 and $0.38. The current price stands at $0.36, placing the stock +0.7% above today's low and -5.4% off the high.

Silexion Therapeutics(SLXN) shares are trading with a volume of 77.09K, against a daily average of 268.04K.

In the last year, Silexion Therapeutics(SLXN) shares hit a 52-week high of $80.00 and a 52-week low of $0.35.

In the last year, Silexion Therapeutics(SLXN) shares hit a 52-week high of $80.00 and a 52-week low of $0.35.

SLXN News

TipRanks 4d
After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring - TipRanks

...

After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring - TipRanks

People also own

Based on the portfolios of people who own SLXN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.